Want to see HK:9933 full AI Analyst Report?
9933 Stock Chart & Stats
HK$1.75
-HK$0.06(-2.32%)
At close: 4:00 PM EST
HK$1.75
-HK$0.06(-2.32%)
Day’s Range― - ―
52-Week RangeHK$1.33 - HK$2.64
Previous CloseN/A
Volume916.00K
Average Volume (3M)337.60K
Market Cap
HK$1.69B
Enterprise ValueHK$1.86B
Total Cash (Recent Filing)HK$167.57M
Total Debt (Recent Filing)HK$859.52M
Price to Earnings (P/E)107.1
Beta1.36
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding1,009,500,000
10 Day Avg. Volume350,800
30 Day Avg. Volume337,600
Financial Highlights & Ratios
PEG Ratio-41.65
Price to Book (P/B)2.64
Price to Sales (P/S)0.38
P/FCF Ratio16.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained top-line expansion through 2025 indicates increasing market penetration and demand for the firm's chemical products. Durable revenue growth helps absorb fixed costs, supports scale economics, and provides a base for future margin recovery or reinvestment into higher-value offerings.
Improved Cash GenerationReturn to positive FCF signals the business can generate internal cash to fund operations and modestly de-lever or invest. While prior volatility exists, a sustained positive FCF trajectory reduces refinancing reliance and materially strengthens medium-term financial flexibility.
Diversified B2B Model & CapabilitiesA mix of trading, manufacturing and distribution plus technical and logistics capabilities creates multiple revenue streams and customer touchpoints. This integrated model supports sticky B2B relationships, potential margin uplift from value-added manufacturing, and resilience to single-channel shocks.
Bears Say
Compressed ProfitabilityVery thin gross and net margins point to weak pricing power and elevated cost pressure versus peers. Persistently compressed margins reduce ability to absorb raw-material swings, constrain retained earnings for reinvestment, and limit long-term return on equity improvement.
Meaningful LeverageA leverage ratio above 1x combined with very thin profitability raises solvency and interest-coverage risks. High indebtedness limits strategic flexibility, increases sensitivity to rate shocks, and makes sustained margin weakness more dangerous for long-term financial stability.
Volatile Cash ConversionLarge swings in operating cash flow and intermittent negative free cash flow reflect working-capital and reinvestment variability. That volatility complicates planning, restricts reliable debt paydown or funding for capex, and increases execution risk across planning horizons.
GHW International News
9933 FAQ
What was GHW International’s price range in the past 12 months?
GHW International lowest stock price was HK$1.33 and its highest was HK$2.64 in the past 12 months.
What is GHW International’s market cap?
GHW International’s market cap is HK$1.69B.
When is GHW International’s upcoming earnings report date?
GHW International’s upcoming earnings report date is Aug 31, 2026 which is in 42 days.
How were GHW International’s earnings last quarter?
GHW International released its earnings results on Mar 30, 2026. The company reported HK$0.007 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.007.
Is GHW International overvalued?
According to Wall Street analysts GHW International’s price is currently Overvalued.
Does GHW International pay dividends?
GHW International does not currently pay dividends.
What is GHW International’s EPS estimate?
GHW International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GHW International have?
GHW International has 1,009,500,000 shares outstanding.
What happened to GHW International’s price movement after its last earnings report?
GHW International reported an EPS of HK$0.007 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.247%.
Which hedge fund is a major shareholder of GHW International?
Currently, no hedge funds are holding shares in HK:9933
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GHW International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-45.41%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.77%
Trailing 12-Months
Company Description
GHW International
GHW International is an investment holding company that manufactures and globally distributes a variety of chemical and pharmaceutical products. Its operations reach across the People's Republic of China, Europe, Vietnam, other Asian regions, and various international markets. The company organizes its business into four primary divisions: Polyurethane Materials, Animal Nutrition Chemicals, Fine Chemicals, and Pharmaceutical Products and Intermediates. The Polyurethane Materials division supplies polymeric methylene diphenyl diisocyanate (PMDI), toluene diisocyanate (TDI), and polymer polyether, which are integral to the production of cushion foams, vehicle interior components, and other lightweight automotive parts. Its Animal Nutrition Chemicals segment provides choline chloride and betaine, essential compounds used in feed formulations for poultry and livestock. The Fine Chemicals division produces various substances, including carboxylic acids, solvents, resins, and oleochemicals. These find applications in paints, dye synthesis, lubricant manufacturing, emulsifiers, cosmetics, flavors, fragrances, and feed additives. Lastly, the Pharmaceutical Products and Intermediates segment manufactures and markets compounds like isooctanoic acid and diethyl sulfate. These are utilized as paint driers, fungicides, preservatives, and pharmaceutical raw materials, as well as in the synthesis of dyes, pesticides, and pharmaceutical intermediates. This segment also offers iodine and its derivatives, along with finished pharmaceutical products, such as cefpodoxime dispersible tablets. GHW International was established in 1995 and its main offices are situated in Nanjing, People's Republic of China.
Technical Analysis
China Risun Group Ltd.
―
Dongguang Chemical Ltd.
―
Dongyue Group Limited
―
China Sanjiang Fine Chemicals Co., Ltd.
―
Lee & Man Chemical Co. Ltd.
―